Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease
Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD. Background: Body-first and brain-first have recently been proposed…Evaluation of Changes in Non-Motor Symptoms in Parkinson’s Disease Patients: A Twelve-Month Follow-Up After Bilateral Deep Brain Stimulation in the Subthalamic Nucleus
Objective: To determine changes in NMS in PD patients twelve months after undergoing DBS implantation in the STN at the Centro Médico Nacional Siglo XXI…Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss
Objective: Examine the interaction between APOE E4 and idiopathic Parkinson’s disease (PD) on age-related hearing loss using a validated web-based speech-in-noise assessment. Background: Age is…Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents
Objective: To determine the presence of prodromal markers of Parkinson’s disease (PD) in Gaucher disease (GD) patients and their parents. Background: GBA gene mutation is…The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia
Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…Association of Autonomic Symptoms with Motor Features of Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network Registry
Objective: To determine the profile of AS and the relationship to motor severity and phenotype in persons with PD in Nigeria. Background: Autonomic symptoms (AS)…Conceptualization of the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS) prototype.
Objective: To outline the process of conceptualizing the prototype for the International Parkinson and Movement Disorder Society Parkinson's Disease Psychosis Rating Scale (MDS-PDPRS). Background: Approximately…Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort
Objective: We aim to study the relationship between clinical features in patients with Parkinson’s disease (PD) and their IL-6 and IL-1β serum levels. Background: According…Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy
Objective: The objective of this study was to explore atypical features in the clinical phenotype of people with Parkinson’s disease (PwP) enrolled in the East…Prodromal Parkinson’s disease in the general population
Objective: To investigate the diagnostic value of the MDS research criteria for the detection of the prodromal phase of Parkinson’s disease (PD) in the general…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 55
- Next Page »
